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ROC Curve Regression Analysis: The Use of
Ordinal Regression Models for Diagnostic Test
Assessment
Anna N. A. Tosteson,1 Milton C. Weinstein,2 Jack Wittenberg,3
Colin B. Begg4
1Department of Medicine and Community and Family Medicine, Dartmouth Medical School, Hanover, New
Hampshire; 2Department of Health Policy and Management, Harvard School of Public Health, Cambridge,
Massachusetts; Department of Radiology, Massachusetts General Hospital, Harvard Medical School,
Cambridge, Massachusetts; 4Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer
Center, New York, New York
Diagnostic tests commonly are characterized by their true positive (sensitivity) and true negative (specificity) classification rates, which rely on a single decision threshold to classify a test result as positive. A more complete description of test accuracy is given by the receiver operating characteristic (ROC) curve, a graph of the false positive and true positive rates obtained as the decision threshold is varied. A generalized regression
methodology, which uses a class of ordinal regression models to estimate smoothed ROC curves has been described. Data from a multi-institutional study comparing the accuracy of magnetic resonance (MR) imaging with computed tomography (CT) in detecting liver metastases, which are
ideally suited for ROC regression analysis, are described. The general regression model is introduced and an estimate for the area under the ROC
curve and its standard error using parameters of the ordinal regression model is given. An analysis of the liver data that highlights the utility of the
methodology in parsimoniously adjusting comparisons for covariates is presented. - Environ Health Perspect 1 02(Suppl 8):73-78 (1994)
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Introduction

widely used model, detailed by Green and
Swets (2), assumes that the responses (or
some monotonic transformation of them)
are distributed according to a normal density function with the parameters of the
density function differing according to true
disease status (e.g., N(u0, ac) for nondiseased patients and distribution N(Qu1, i )
for diseased patients). Under this model,
estimation of ROC curve parameters is
accomplished using a maximum likelihood
algorithm developed by Dorfman and Alf
(3). Swets and Pickett (4) discuss in detail
the uses of the Dorfman and Alf methodology for the analysis of diagnostic systems.
The primary limitation of the Dorfman
logic literature.
Smoothed ROC curve estimation is and Alf approach is the difficulty that
usually completed using a model from sig- occurs when covariates must be considered
nal detection theory, which assumes the in the analysis. Because the signal detection
existence of an unobserved scale along model provides no facility for incorporatwhich responses are distributed. The most ing covariates directly into the analysis, one
must form subgroups and estimate ROC
curves separately in each. This approach
This paper was presented at the 4th Japan-US precludes the consideration of continuous
Biostatistics Conference on the Study of Human covariates and often becomes impractical
Cancer held 9-11 November 1992 in Tokyo, Japan.
This work was supported in part by National because of sparse data. The need to accommodate covariates is exemplified by data
Cancer Institute Contract NO. I-CM-47564.
Address all correspondence to Anna N. A from the liver protocol of the magnetic resTosteson, Clinical Research, HB 7505, Dartmouth- onance imaging (MR) collaborative workHitchcock Medical Center, One Medical Center Drive,
Lebanon, NH 03756. Telephone (603) 650-6390. Fax ing group*, which was designed to compare
(603) 650-8208.
MR at several magnet field strengths with

For a diagnostic modality, the receiver
operating characteristic (ROC) curve presents a varied graphic display of all true positive and false positive rate pairs obtained as
the decision threshold used to classify a
group of diseased and nondiseased subjects
as positive (i.e., having disease). Because
the ROC curve depicts test performance
across all decision thresholds, it is a more
general measure of diagnostic performance
than sensitivity (true positive rate) and
specificity (true negative rate), which rely
on a single threshold. Metz (1) reviewed
the use of ROC curve analysis in the radio-
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dynamic, enhanced computed tomography
(CT) in the detection of liver metastases in
patients with primary malignancies of the
breast, colon, lung, and pancreas. Among
the factors that may influence the accuracy
of MR and CT and that must be considered in the analysis are patient-specific
covariates such as primary tumor site,
modality-specific covariates such as magnet
field strength, and external covariates such
as reviewer.
Recently, Tosteson and Begg (5)
described an approach to ROC curve estimation which includes the Dorfman and
Alf model as a special case of a much more
general class of models. To estimate ROC
curve parameters from rating experiment
data, the general regression approach uses
one of a class of ordinal regression models
developed by McCullagh (6).
*The magnetic resonance imaging collaborative working group was comprised of radiologists from
Bowman-Gray School of Medicine, Cleveland Clinics,
Duke University, Massachusetts General Hospital, and
the University of California at San Francisco. This
group was formed to assess the diagnostic accuracy of
MR in the detection and characterization of disease at
seven skeletal sites in comparison to the currently
used standard modality (or modalities) at each disease
site.
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In this article, our goal is to illustrate
how ROC regression analysis facilitates
diagnostic test assessment. We first present
a detailed description of issues in the analysis of data from the multi-institutional liver
protocol. Next we introduce the ordinal
regression model and use its parameters to
give an estimate for the commonly used
ROC curve summary statistic, the area
under the curve, and its standard error. A
detailed analysis of the liver protocol data
is presented.

The Liver Protocol
In patients with cancer, it is important for
patient management that the disease be followed closely and that the presence or
absence of hepatic metastases be correctly
diagnosed. To determine which modality is
most accurate in the diagnosis of metastases the MR collaborative working group
collected data according to the liver protocol described here.
Consecutive patients who were referred
for investigation of possible liver metastases,
or who had histologically documented liver
metastases and had documentation (within
30 days of enrollment) of a primary malignant tumor of the breast, colon, lung, or
pancreas, were prospectively enrolled in the
study from 1985 through 1987 at
Bowman-Gray School of Medicine,
Cleveland Clinics, Duke University,
Massachusetts General Hospital, and the
University of California at San Francisco.
Patients who did not have both MR and
CT examinations completed within a 14day period were excluded from the study.
Each study subject was then followed for
ultimate verification of true disease status,
meaning in this case the presence or
absence of liver metastases.
Each subject's disease status was determined by pathology or according to clinical
criteria specified in the protocol, and was
carefully documented on follow-up forms
that were completed and submitted within
six months of the original CT and MR
examinations. The criteria for clinical
proof of liver metastases were as follows:
enlargement of focal metastasis on followup CT scan or MR image, abnormal liver
function tests and presence of extrahepatic
metastases, or abnormal liver function tests
and subsequent treatment for liver metastases. Analogous criteria were used to document benign liver abnormalities, which
were considered as normal for the purpose
of assessing the accuracy of MR in the
detection of liver metastases.
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The Rating Experiment
Prior to the documentation of true disease
status the CT, MR pairs for each subject
were sent from each institution to a central
review meeting. The central review process
consisted of a rating experiment in which
one radiologist from each institution participated.
The reviews were generally carried out
over a 2-day period during which the five
radiologists (reviewers) participated in four
review sessions. For each radiologist a
review session consisted of rating a batch of
20 to 40 CT scans or MR images. The
review was designed so that each subject
received two independent ratings of both
their CT scan and MR image.
Reviewers were blinded to patient history
and all patient characteristics except for
primary tumor site. Primary tumor site was
made available to the reviewing radiologists
because it was judged that omission of this
critical information would hamper the
radiologists' review of both modalities and
would therefore not fairly represent either
modality as used in clinical practice.
In keeping with the blinded review
process, reviewers were not allowed to rate
examinations from their own institution,
because their interpretation of MR and CT
for these cases could be influenced by their
knowledge of the patient's subsequent clinical course. In addition, with two exceptions (i.e., two sessions, one batch in each),
no reviewer rated the CT, MR pair from
an individual subject. These steps were
taken in an effort to minimize bias in test
interpretation (7,8). For example, if a
reviewer was first to read the MR images
for a group of subjects and later to read
their CT scans, the ratings for the CT
scans could be influenced by the reviewer's
recall of the MR images. This could cause
the CT ratings to appear more accurate
than they would have been if rated independently, thus biasing the comparison of
MR and CT.
The radiologists had been familiarized
with the data form used in the rating
experiment prior to the review, and were
asked to give the likelihood on a scale from
0 to 100 that liver metastases were present.
Issues in the Data Analysis
The primary goal of the data analysis is to
compare MR with CT in the detection of
liver metastases. The liver data include
images from five institutions, which operate
MR units at four separate magnet field
strengths, and afford a unique opportunity
to assess the comparability of MR at each
field strength with CT. In making these

comparisons, we are concerned with factors
that may influence either the accuracy of
the modality under study or the manner in
which it is interpreted. As outlined below,
we consider three classes of factors: patient
specific, modality specific, and external.
Patient-specific factors refer to particular patient and disease characteristics that
may influence the accuracy of MR or CT
or its interpretation. Some questions that
we address are the following: Does primary
tumor site (or age, gender, etc.) influence
the criteria that reviewers used for assigning likelihoods of metastases to subjects?
Alternatively, can any apparent differences
between MR at varying magnet strengths
and CT be explained by confounding due
to patient and disease characteristics? The
latter is important because, although the
paired design of the protocol ensures balance
of patient characteristics for the overall
MR/CT comparison, this balance is not
ensured for the comparisons between MR
units using different magnet strengths and
CT, because magnet field strengths differ
across sites.
Modality-specific factors refer to characteristics of the modality that could
influence its accuracy or interpretation,
such as magnet field strength and the study
year in which the examination was performed. Here we ask, does magnet field
strength affect the accuracy of MR? Has
there been a change in MR or CT over the
three years in which the study was conducted due to modifications in the technology or due to improvements in the
reviewers' interpretation of MR?
External factors encompass additional
features of the study design that could confound the MR/CT comparisons. The effect
that the reviewer has on the accuracy of
MR and CT is of particular interest here.
We ask: What is the nature of interobserver variability? Are some reviewers better
than others or do all reviewers operate
along the same ROC curve? The answers
to these questions are of intrinsic interest
and have strong implications for the comparison between MR and CT.
Although some of the issues discussed
here could be accommodated by taking
advantage of the paired design and limiting
the analysis to a comparison of MR and
CT within each site, doing so would result
in a loss of power. Furthermore, because
no reviewer read both the CT and MR of
the same subject, the paired comparisons
might be confounded by reviewer effects.
Thus, the MR/CT comparison is ideally
suited to a regression approach that allows
us to control potential confounders. In the
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next section we introduce such a model
and specify how it can be used to estimate
ROC curve parameters.

Ordinal Regression Model
Prior to the analysis, the responses (likelihoods) assigned by the reviewers to each
subject's MR image and CT scan are
grouped into J ordered response categories,
with the Jth category being most indicative
of disease. Let Ybe the ordinal variable
representing these response categories (i.e.,
Ytakes on the values 1,2,...,J). We wish to
model Pr[ Y<j X], the probability of a
response in category j or lower for subjects
with covariates X To define an ROC curve
it is necessary that one component of Xbe
an indicator of true disease status. Assume
momentarily that X is a scalar (i.e., there
are no covariates other than disease status)
and that X= 1 if metastases are present and
X= 0 otherwise. Then the ROC curve is a
plot of 1-Pr[ Y<jIX= 1], the proportion of
true positives (TPR), against
1-Pr[Y<jIX=0], the proportion of false
positives (FPR), as j is varied.
We model Pr[ Y<j X] using one of a
class of general ordinal regression models
(6). The model is

Pr[ Y<jI X] = 4[(E -a'X){exp(P'X)}F']
[1]

maximized log likelihood attainable for a
perfect model (i.e., a full model, one using
all the degrees of freedom available) (9).
Hierarchical models are compared using
the difference in the deviance statistic,
which has a chi-square distribution with
degrees of freedom equal to the difference
between the number of parameters fit in
each model.
The plot of the empirical ROC curve(s)
that is obtained by varying the cutoff category for classifying subjects as having a positive rating and plotting the resulting true
positive and false positive error rate pairs is
also useful in checking the correspondence
between the fitted curves and the raw data.
The Area Under the ROC Curve
The area under the ROC curve, which is
related to the Wilcoxon or Mann-Whitney
statistic (10), has become a commonly used
summary measure in ROC curve analyses
(11,12). Although this measure is global
and not ideal in settings were ROC curves
cross, we present an estimate for the area
under the ROC curve using parameters
derived from Equation 1 for completeness.
The area under any ROC curve is easily
obtained from the estimated parameters a
and ,, using the notation and equations
detailed below. Let X= (X1,X*), where X1
represents true disease status and X* represents all other covariates. Then we define
the covariate vectors for nondiseased and
diseased subjects as X0= (0,X8) and Xi = (1,
X*), respectively. The vectors Ao and X1
differ depending on whether we are referring to the location regression, a'X, or the
scale regression, P'X However, to simplify
notation we assume that when associated
with a, Xis a vector of dimension 1xN1
containing covariates included in the location regression and when associated with B,
Xis a vector of dimension lxN2 containing
covariates included in the scale regression.
The area under the ROC curve, as
described by Dorfman and Alf (3), and
Swets and Pickett (4) is area = A =
cD[(F_pf)/{f2l+G2}1112], where p0, aO2,0p'
cYi are parameters for the normal density
functions according to which responses
from diseased (N(po,af )) and nondiseased
patients (N(pi,a 2)) are distributed. In
terms of the ordinal regression model
(Equation 1) parameters, the area estimator

where 4D(.) is the cumulative normal distribution function and the e are the J-1
estimated cutoff values for the boundaries
between the J response categories. Note
that this model accommodates both a location regression, a'X, and a scale regression,
exp(,'X), although the factors included in
each regression need not be the same. A
more general statement of Equation 1
would replace D(.) with any monotonically
increasing link function. However, in the
simple case where X represents a single
covariate corresponding to true disease status, Equation 1 corresponds to the model
given by Dorfman and Alf (3) as described
by Tosteson and Begg (5).
Maximum likelihood estimates for the
model parameters are obtained by an iteratively reweighted least squares algorithm
(6,9). Additional computations using the
estimated parameters a and P are necessary
to generate the ROC curve coordinates
is
(FPR, TPR) for curve plotting.
Model selection is guided by the estimated coefficients, a and P, their associ- A = g(a,4) = (D[(a'Xj-a'X3)/{exp(2P'X)+
ated standard errors, and the deviance
[2]
exp(2'X))}1/2].
statistic, which is defined as minus twice
Let N=N1+N2 represent the total
the difference between the maximized log
likelihood for the current model and the number of covariates in location and scale
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models, respectively, where a variable that
appears in both locations is counted twice.
Let Ii = (0,...,1,0,...,0) represent a vector
of appropriate dimension with zeroes
everywhere except for the ith entry. Then
the standard error for Equation 2 is derived
using the delta method as SE[ea,P)1=
(G*£*G') 1/2, where G= [ag(a,)l/aa,
ag(a,P)/a
pi] is a lxNvector of derivatives
of the form given below and where I is the
variance-covariance matrix for the parameters a, P. The partial derivatives that comprise G are of the form:

dg(a,1) =(I-Xj-I-XO)t(afl) r(p) 1/2
and

dg(a,/3)
dpf

=(- 1/2)(a'4X-a'XO)

{2IlXjexp(2fi'X)

+2IXoexp(2flX)} t(a4,) r(#)-312
where t(a,3)=(2iY1/2exp({-1/2(a'Xj-a'X0)
r(f3'12} ) and r(#)=exp(2P'Xj)+exp(2A'X).
An estimate for the standard error of
the difference between two area estimators
is obtained analogously.

Description of Modeling Approach
In addition to true disease status, the
patient-specific, modality-specific, and external factors described earlier must be
induded in our ROC regression. These factors may influence the ROC curves as either
main effects or interactions with true disease
status. Tosteson and Begg (5) describe in
detail the impact that these terms have on
the shape of ROC curves estimated using
Equation 1. They show that, in the location
regression, the covariate main effects do not
affect the shape of the ROC curve, while
covariate interaction terms define different
curves for each level of the covariate.
Covariate main effects in the location model
are interpreted to imply movement along a
single ROC curve. They indicate that a difference exists in the criteria for assigning
likelihoods to subjects for differing levels of
the covariate. That is, the interpretation of
the modality is influenced by the covariate.
In the scale regression, covariate main effects
are shown to shift the curves to either the
lower left or the upper right of the graph
(away from symmetry), while interactions
between covariates and true disease status
define ROC curves that cross each other for
varying levels of the covariate(s).
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To minimize the complexity of model
selection when both location and scale
models are available, we developed a general
approach in which we first fit true disease
status in both location and scale models.
True disease status was included in the
scale model because of the finding that this
term is usually of importance in modeling
radiologic data (13). Next, expanded location models were considered and selection
of hierarchical models was completed using
the deviance statistic. Using this approach
we either included or excluded all indicators
for a particular covariate (e.g., primary
tumor site would include indicators for
three of the four groups). Once location
modeling was completed, expanded scale
models were considered. Scale modeling
was done sparingly because the iterative
fitting routine failed to converge for many
complicated scale models.

Table 1. Distribution of patient charcteristics and percent with mestastases by characteristic.
% with
Proportion of subjects
characteristic
with mestatases
Tumor site
Breast
20
Colon
45
21
Lung
Pancreas
14
Total %
100
Age
<50
25
.50
75
Total %
100
Sex
Male
47
Female
53
Total %
100
Magnet field strength
Low
31
Middle
42
High
27
Total %
100

52
58
34
52

59
48
51
50

Table 2. Likelihood ratios for MR and CT based on rating table data (i.e., for unadjusted analysis).
Likelihood ratio'
MR
CT
Category
1
0.20
0.14
2
0.16
0.36
3
0.42
0.45
4
0.45
0.61
5
1.64
2.06
6
5.22
4.40
7
10.74
9.80
aThe likelihood ratio is equal to the proportion of
responses in a given category for diseased subjects
divided by the proportion of responses in that category
for nondiseased subjects.

51
50
51

Results of Data Analysis
A total of 502 patients were reviewed during
the course of the study, with follow-up
pathology available for 326 (65%). Although
this raises the concern that verification bias
(7,8) may pose a problem in the analysis,
this is unlikely to be a problem because the
majority of subjects without disease
verification are those entered late in the
study. Of those with verified disease status,
165 (51%) have documented liver metastases. The data are comprised of the following mix of primary malignancies: 20%
breast, 45% colon, 21% lung, and 14%
pancreas (Table 1).

Empirical and Unadjusted ROC Curves
For the analysis, the 100 point rating scale
was collapsed into seven categories (i.e., 0,
1 to 19, 20 to 39, 40 to 59, 60 to 79, 80 to
99, 100). The rating data for MR and CT
using this categorization are given in Table
2. The empirical data points and smoothed
curves were fit to these data using Equation
1 (Figure 1). We note the apparent similarity between the unadjusted curves.
Generally, crossing ROC curves, which are
characteristic of models that include interaction terms in the scale model, indicate
that no modality is clearly superior.
To answer questions regarding magnet
field strength we divide the MR units into
three groups: low (0.15 T [teslas] unit),
mid (0.35 T, 0.5 T, and 0.6 T units), and
high (1.5 T unit). These groups comprise
31, 42, and 27% of the sample, respec-

tively. The empirical data points and
curves estimated using Equation 1 for MR
at each field strength in comparison to CT
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are given in Figure 2. The curve for high
field strength MR is higher than the other
curves, indicating that it may be superior to
the other modalities in detecting liver
metastases. The curves for low- and midfield strength MR cross, with low MR having higher specificity than mid MR at
sensitivities below approximately 70%. The
areas under the ROC curves are quite simiOA
0.6
0.8
lar at 0.87 ± 0.02 for CT, 0.85 ± 0.02,
FPR
0.87 ± 0.01, and 0.92 ± 0.02 for low-, mid-,
and high-field strength MR, respectively.
Figure 1. ROC curves for the diagnosis of liver metas-

Analyses of Single Covariates
Before undertaking formal comparisons, a
series of analyses assessing the individual
impact of factors on the ROC curves for
MR and CT were completed to understand
the broad associations present in the data.
The results of two of these analyses are
described.
Primary Tumor Site
An analysis considering primary tumor site
indicated that both modalities detect liver
metastases most accurately for colon primaries with decreasing accuracies evident
for lung, breast, and pancreatic primaries,
respectively. A single curve represents both
combined MR and CT (Figure 3). These
curves are representative of the family of
curves produced for varying levels of a
covariate (primary tumor site) when interaction effects are significant in the location
model or when main effects are significant
in the scale model.

tases, CT versus combined MR. True positive rate (TPR)
is shown on the ordinate and false positive rate (FPR)
on the abscissa. Areas under the curves are not significantly different.

TPR
0.8-.
I
0.6

0.4

High MR

*
A*~

.1

Mid MR
Low MR

*m

- CT
0.2-

0

I
02

0.4

0.6

0.8

FPR

Figure 2. ROC curves for the diagnosis of liver metastases, CT versus categorized magnetic strength units.
Areas under the curves are not significantly different
among all of the imaging techniques.
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0.2

0.4

0.6

0.8

1

0

0.2

FPR
Figure 3. ROC curves for detection of liver metastases
according to primary source of metastases. A single
curve is used to represent both CT and combined MR.
Area under curve for detecting colonic metastases is
significantly greater than that for pancreatic metastases (p<0.001). No other significant differences were
found.

0.4

0.6

0.8

FPR
Figure 4. ROC curve for diagnosis of liver metastases
adjusted for interobserver error and primary tumor site,
CT versus categorized magnetic strength units. Area
under curve comparisons are not significantly different.

parisons could be confounded by the

two of the
five participating institutions changed

reviewer effects. That is, since some reviewers are "better" than
if the "best"
reviewer
more
one
our

reviewers. Thus,

comparisons.

Reviewer Effects

Over the

course

of the study,

a

total of seven reviewers

participated in the rating experiment.

When

examined the impact of interobserver variability on the ROC curve, using
the ordinal regression model, we found
reviewer effects that were significant when
included in both the location and scale
models as main effects and as interaction
terms. The main effects for reviewers
demonstrate that reviewers use different
criteria or cutpoints for assigning likelihoods to subjects; more important, the
significance of the interaction terms in the
location model indicates that reviewers
have different ROC curves along which
they operate. That is, some reviewers are
better diagnosticians than others.
we

Implications

Primary tumor site and reviewer are both
important factors to control for in the
MR/CT comparison. Because colon primaries are more easily identified than pancreatic primaries, if one MR field strength
imaged a disproportionate share of patients
with colon primaries, it could falsely
appear superior to the other MR field
strengths. Indeed a chi-square test of association between tumor site and magnet
field strength was highly significant
(p<O.OOl). Although this problem could be
circumvented by restricting the comparisons to paired data within each institution,
this would result in a loss of power.
Furthermore, no reviewers read both the
CT and MR for each case and paired com-
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others,
reads relatively
of
modality than another this could bias

Analysis with Multiple Covariates
In an overall analysis using Equation 1 to
compare MR at each field strength with
CT, we considered adjusting for primary
tumor site, reviewer, gender, age, and year
of exam. The factors that influenced the
accuracy of MR and CT were reviewer and
primary tumor site (Table 3). In the location
model, reviewer main and interaction
effects and tumor site interaction effects
were statistically significant. In practical
terms, the importance of the main effects
implies that the criteria for assigning a likelihood that liver metastases are present to
each subject varied across reviewers. The
importance of the interaction terms implies
that even after controlling for all factors of
importance, some reviewers are better diagnosticians than others and that it is easier
to accurately assess the presence of liver
metastases for colon primary tumors than
for lung, breast, or pancreatic primaries.
Larger coefficients for interaction terms are
indicative of better diagnostic accuracy (5).
After adjusting for reviewer and tumor, we
found that no modality effects were of
importance in the location model, indicating that no modality is clearly superior to
any other.
In the scale model, reviewer and tumor
main effects were the most important
covariates. Main effects in the scale model
have a similar impact to interactions in the
location model; however, smaller

Table 3. Estimated coefficients and standard errors for
final adjusted model.
Covariate
Location model Scale model
Disease status
0.7383 (0.10) 0.1808 (0.11)
Reviewer main effectsa
Reviewer A
-1.3730 (0.34) 1.8300 (0.18)
Reviewer B
-0.5895 (0.14) 0.9987 (0.15)
Reviewer C
-0.5712 (0.18) 1.2490(0.17)
Reviewer D
-0.1576 (0.09) 0.7562 (0.13)
Reviewer E
-0.5653 (0.12
0.9365 (0.14)
Reviewer F
-0.2380 (0.08) 0.1812 (0.13)
Reviewer interactionsa
Reviewer A
3.5440 (0.64)
Reviewer B
1.2770 (0.24)
Reviewer C
2.3640 (0.45)
Reviewer D
0.8587 (0.16)
Reviewer E
1.1980 (0.20)
Reviewer F
0.2958 (0.13)
Tumor main effectsb
Breast
0.1725 (0.09)
Lung
-0.0399 (0.09)
Pancreas
0.1801 (0.11)
Tumor interactions b
Breast
-0.1121 (0.12)
Lung
-0.1752 (0.11)
Pancreas
-0.3654 (0.14)
Modality main effectsC
Low MRI
-0.4231 (0.12)
Mid MRI
-0.0003 (0.13)
High MRI
-0.1842 (0.14)
Modality interactionsc
Low MRI
0.6379 (0.18)
Mid MRI
-0.0298 (0.17)
High MRI
-0.0025 (0.19)
'Comparisons are with Reviewer G. b Comparisons are
with Colon Primaries. CComparisons are with CT.

coefficients are indicative of better diagnostic accuracy (5). An examination of the
coefficients for tumor main effects indicates that after adjusting for all other factors, lung primaries were slightly, but not
significantly, more accurately detected than
colin primaries. As seen above, pancreatic
primaries had the lowest (i.e., largest
coefficient) ROC curve.
After adjustment for all other covariates, modality effects were of importance in
the scale model. An examination of the
modality coefficients indicates that only
low field strength MR differs significantly
from CT. However, the statistically
significant coefficient for the interaction
between low field strength MR and true disease status indicates the existence of crossing ROC curves. Thus, low-field strength
MR is not uniformly superior or uniformity poorer than CT in detecting the presence of liver metastases.
To more fully understand the impact of
the final model estimates (Table 3) on the
ROC, curve a graphical presentation is useful. Given that there were seven reviewers
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and four primary tumor sites represented
in the liver protocol data, the adjusted
analysis produces 28 groups, in which there
are four ROC curves (one for each modality). The relative position of the curves for
each modality was the same within each
reviewer and primary tumor site combination. Figure 4 shows composite adjusted
curves, which were derived by including all
parameter estimates from the final adjusted
model in the regression model and weighting them equally to reflect what would be
expected under a balanced design. The high
field strength MR had higher sensitivity
and specificity than both mid MR and CT
for the entire range, but these differences
were not statistically significant in terms of
the regression parameter estimates or in
terms of area under the ROC curve. As
indicated by the importance of interaction
terms in the scale model, we see that the
ROC curve for low field strength MR
crosses the other curves. We see that at
lower sensitivities the low field strength
MR was superior to all other modalities. It
is noted that when using these modalities
in screening patients for liver metastases,
higher sensitivity is usually preferred to
higher specificity.

Discussion
Our analysis demonstrates the role of ordinal
regression models in diagnostic test assessment when tradeoffs between sensitivity
and specificity must be captured through
estimation of ROC curves. One clear
advantage of the analysis that we present is
the ease with which multiple covariates
were assessed. Using traditional ROC
curve methods, the subgroup analyses
would have been tedious and in some cases

impossible to complete or interpret due to
sparse data.
The rating data used in our example
represented ordinal ratings on a 0- to 100point scale. In most rating experiments, a
more limited set of categories is specified.
When reviewers rated the likelihood that
metastases were present, however, they
tended to use a limited set of values (e.g.,
10, 25, 50, etc.) for assigning ratings. To
complete the analysis, the reviewers' ratings
were grouped into seven response categories. The results of the analysis were
unchanged when ratings were collapsed
into twelve rather than seven response categories.
Swets and Pickett (4) describe two general
approaches to the issue of multiple ratings
(more than one review per subject) by different reviewers. The first involves pooling
the ratings for each subject and treating
them as independent observations. The
second involves averaging parameters and
summary measures from each reviewer's
curve. In contrast, we approach the multiple rating problem by including reviewer
effects in the ordinal regression model. The
estimation of reviewer effects not only
indicated that differences exist between
reviewers, but also identified the nature of
those differences. The estimated reviewer
effects indicated that the decision criteria
for the raters were quite different and that
some reviewers were better diagnosticians
than others, and therefore required us to
control all modality comparisons for these
important differences.
Our approach to these data, while
offering several advantages, also has some
limitations. First, our approach does not
accommodate the pairing of the data.

Second, the fixed-effects nature of the
model used does not allow us to accommodate intrareader correlations. Further work
is required before these limitations can be
overcome.
Biases in radiologic test assessment are
common and have been reviewed by Begg
and McNeil (8). An attempt was made in
our study to avoid test interpretation biases
by the blinding procedures used in the rating
experiment. Biases occurring as a result of
disease spectrum, or differences in case mix
were partially avoided by adjusting for
patient-specific factors in the analysis. These
adjustments are more easily made using the
ordinal regression model than using standard ROC curve techniques, because of the
facility provided by the ordinal regression
model for subgroup analyses. As stated previously, we do not expect that verification
bias is a serious problem in this analysis.
The potential over-representation of
subjects with liver metastases in our data,
relative to what would be expected in a
population of patients with primary malignancies of the breast, colon, lung, and pancreas, is unlikely to bias our comparison of
MR and CT. It does, however, make it
likely that estimates of the sensitivity of
both modalities in detecting liver metastases are overestimated using any form of
ROC curve estimation.
In summary, the ordinal regression
model provided a flexible and parsimonious method for analyzing the liver protocol
data. The facility that it provides for
appropriately adjusting ROC curves for
potential confounders and other relevant
factors enhances our capacity for carrying
out complex comparisons when many factors must be controlled for in the analysis.
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